pyrimidin-2-one beta-ribofuranoside has been researched along with Carcinoma, Hepatocellular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, JB; Durkin, M; Factor, VM; Gillen, MC; Holczbauer, A; Marquardt, JU; Raggi, C; Seo, D; Thorgeirsson, SS | 1 |
| Andersen, JB; Conner, EA; Factor, VM; Lee, YH; Marquardt, JU; Raggi, C; Seo, D; Thorgeirsson, SS | 1 |
| Aizawa, K; Hata, K; Kato, N; Nakabayashi, K; Nakamura, K; Tanoue, A; Yamauchi, J | 1 |
3 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Epigenetic reprogramming modulates malignant properties of human liver cancer.
Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cytidine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Gene Expression; Gene Knockdown Techniques; Humans; Liver Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms, Experimental; Neoplastic Stem Cells; Spheroids, Cellular | 2014 |
An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; CpG Islands; Cytidine; DNA Methylation; Epigenesis, Genetic; Gene Expression Profiling; Genome, Human; Humans; Liver Neoplasms; Mice; Transplantation, Heterologous | 2010 |
DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspases; Cell Proliferation; Cytidine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Hep G2 Cells; Humans; Liver Neoplasms; MAP Kinase Signaling System; Phosphorylation | 2013 |